20 June 2013
Keywords: mmrc, keryx, initiate, ph, krx-0401, study, usa-based
Article | 08 January 2007
The USA-based Multiple Myeloma Research Consortium and Keryx Biopharmaceuticals have initiated a multicenter Phase I clinical program
to explore the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 January 2007
15 January 2007
19 June 2013
© 2013 thepharmaletter.com